Working out of Copenhagen, with affiliates in San Francisco and Boston, Novo Holdings is a world-wide life science investor/ venture capital firm.
Novo Holding's mission is to be a supportive owner of the Novo Group companies and to make a growing impact on health, science, and society by generating long-term returns on the assets of the Novo Nordisk Foundation.
Novo Holdings employs investment and business professionals focused on delivering attractive returns for the benefit of the Novo Nordisk Foundation.
Timeline
Funded Companies
Inogen is a Goleta, California-based company founded in 2001. They develop and manufacture lightweight, portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions.
A New Zealand industrial biotechnology company developing a gas fermentation platform for converting concentrated industrial emissions into valuable chemicals.
The Protein Brewery is a Breda-based developer and manufacturer animal-free-based protein based on fungi fermentation processes.
A company creating sustainable design solutions with biomaterials. It was founded in 2013 and is located in San Francisco, California.
A company developing diagnostic monitoring solutions for early diagnosis and treatment of cardiac arrhythmia
Verona Pharma is a London-based biotechnology company working to discover new drugs for the treatment of chronic respiratory diseases.
